Article

Identification of an Intestinal Folate Transporter and the Molecular Basis for Hereditary Folate Malabsorption

Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA.
Cell (Impact Factor: 33.12). 01/2007; 127(5):917-28. DOI: 10.1016/j.cell.2006.09.041
Source: PubMed

ABSTRACT Folates are essential nutrients that are required for one-carbon biosynthetic and epigenetic processes. While folates are absorbed in the acidic milieu of the upper small intestine, the underlying absorption mechanism has not been defined. We now report the identification of a human proton-coupled, high-affinity folate transporter that recapitulates properties of folate transport and absorption in intestine and in various cell types at low pH. We demonstrate that a loss-of-function mutation in this gene is the molecular basis for hereditary folate malabsorption in a family with this disease. This transporter was previously reported to be a lower-affinity, pH-independent heme carrier protein, HCP1. However, the current study establishes that a major function of this gene product is proton-coupled folate transport required for folate homeostasis in man, and we have thus amended the name to PCFT/HCP1.

Download full-text

Full-text

Available from: Myles H Akabas, Sep 01, 2015
0 Followers
 · 
121 Views
 · 
52 Downloads
  • Source
    • "W organizmie człowieka foliany ulegają przekształceniu w biologicznie aktywną postać – kwas tetrahydrofoliowy (THF) w dwustopniowej reakcji katalizowanej przez reduktazę dihydrofolianową. THF z pomocą witaminy B6 jest konwertowany do 5,10 – metylotetrahydrofolianu (MTHF), a następnie przez reduktazę MTHF z udziałem witaminy B 2 do 5-metyloTHF [61]. 5-me- tyloTHF jest donorem grupy metylowej w reakcji konwersji homocysteiny do metioniny, katalizowanej przez syntazę metioniny w obecności witaminy B 12 [3] [24]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The number of overweight and obese people is increasing at an alarming rate, especially in the developed and developing countries. Obesity is a major risk factor for diabetes, cardiovascular disease, and cancer, and in consequence for premature death. The development of obesity results from the interplay of both genetic and environmental factors, which include sedentary life style and abnormal eating habits. In the past few years a number of events accompanying obesity, affecting expression of genes which are not directly connected with the DNA base sequence (e.g. epigenetic changes), have been described. Epigenetic processes include DNA methylation, histone modifications such as acetylation, methylation, phosphorylation, ubiquitination, and sumoylation, as well as non-coding micro-RNA (miRNA) synthesis. In this review, the known changes in the profile of DNA methylation as a factor affecting obesity and its complications are described.
    Postępy Higieny i Medycyny Doświadczalnej (Advances in Hygiene and Experimental Medicine) 11/2014; 68:1383-1391. · 0.63 Impact Factor
  • Source
    • "MTX, as an analogue of FA for high structural similarity, can enter cells by reduced FA carrier, proton-coupled FA transporter, or membrane-associated FA receptor [13-15]. MTX could inhibit dihydrofolate reductase (DHFR) activity and stop FA cycle, and in turn inhibit the DNA synthesis and cell proliferation, and finally drives cells to death [16-18]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Recently, methotrexate (MTX) has been used to target to folate (FA) receptor-overexpressing cancer cells for targeted drug delivery. However, the systematic evaluation of MTX as a Janus-like agent has not been reported before. Here, we explored the validity of using MTX playing an early-phase cancer-specific targeting ligand cooperated with a late-phase therapeutic anticancer agent based on the PEGylated chitosan (CS) nanoparticles (NPs) as drug carriers. Some advantages of these nanoscaled drug delivery systems are as follows: (1) the NPs can ensure minimal premature release of MTX at off-target site to reduce the side effects to normal tissue; (2) MTX can function as a targeting ligand at target site prior to cellular uptake; and (3) once internalized by the target cell, the NPs can function as a prodrug formulation, releasing biologically active MTX inside the cells. The (MTX + PEG)-CS-NPs presented a sustained/proteases-mediated drug release. More importantly, compared with the PEG-CS-NPs and (FA + PEG)-CS-NPs, the (MTX + PEG)-CS-NPs showed a greater cellular uptake. Furthermore, the (MTX + PEG)-CS-NPs demonstrated a superior cytotoxicity compare to the free MTX. Our findings therefore validated that the MTX-loaded PEGylated CS-NPs can simultaneously target and treat FA receptor-overexpressing cancer cells.
    Nanoscale Research Letters 07/2014; 9(1):363. DOI:10.1186/1556-276X-9-363 · 2.52 Impact Factor
  • Source
    • "In the last decade, several heme transporters have been identified, including heme carrier protein-1 (HCP1; Qiu et al., 2006; Laftah et al., 2009), HRG-1 (Rajagopal et al., 2008; White et al., 2013), and FLVCR1 and 2 (Quigley et al., 2004; Keel et al., 2008; Duffy et al., 2010), but their significance in intestinal iron absorption remains to be elucidated. For non-heme iron absorption, ferric iron [Fe(III)] in the diet must be reduced by a ferrireductase duodenal cytochrome b561 (Dcytb) to ferrous iron [Fe(II)] before the divalent metal transporter 1 (DMT1, also known as DCT1 or NRAMP2) can transport iron across the apical membrane into the cytosol of duodenal epithelial cells (socalled enterocytes; Gunshin et al., 1997; McKie et al., 2001). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Iron regulatory proteins (IRPs) regulate the expression of genes involved in iron metabolism by binding to RNA stem-loop structures known as iron responsive elements (IREs) in target mRNAs. IRP binding inhibits the translation of mRNAs that contain an IRE in the 5'untranslated region of the transcripts, and increases the stability of mRNAs that contain IREs in the 3'untranslated region of transcripts. By these mechanisms, IRPs increase cellular iron absorption and decrease storage and export of iron to maintain an optimal intracellular iron balance. There are two members of the mammalian IRP protein family, IRP1 and IRP2, and they have redundant functions as evidenced by the embryonic lethality of the mice that completely lack IRP expression (Irp1 (-/-)/Irp2(-/-) mice), which contrasts with the fact that Irp1 (-/-) and Irp2 (-/-) mice are viable. In addition, Irp2 (-/-) mice also display neurodegenerative symptoms and microcytic hypochromic anemia, suggesting that IRP2 function predominates in the nervous system and erythropoietic homeostasis. Though the physiological significance of IRP1 had been unclear since Irp1 (-/-) animals were first assessed in the early 1990s, recent studies indicate that IRP1 plays an essential function in orchestrating the balance between erythropoiesis and bodily iron homeostasis. Additionally, Irp1 (-/-) mice develop pulmonary hypertension, and they experience sudden death when maintained on an iron-deficient diet, indicating that IRP1 has a critical role in the pulmonary and cardiovascular systems. This review summarizes recent progress that has been made in understanding the physiological roles of IRP1 and IRP2, and further discusses the implications for clinical research on patients with idiopathic polycythemia, pulmonary hypertension, and neurodegeneration.
    Frontiers in Pharmacology 06/2014; 5:124. DOI:10.3389/fphar.2014.00124 · 3.80 Impact Factor
Show more